Clinical significance of lymph node dissection in renal cell carcinoma

Scandinavian Journal of Urology and Nephrology

Volumn 39, Issue 1, 2005, Pages 30-35

  Matsuyama, Hideyasu ^a   Hirata, Hiroshi ^a   Korenaga, Yoshihito ^a   Wada, Takashi ^b   Nagao, Kazuhiro ^a   Yamaguchi, Shiro ^a   Yoshihiro, Satoru ^a   Naito, Katsusuke ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Wada Urological Clinic   (Japan)

Author keywords

Lymph node dissection; Metastasis; Prognosis; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2;

ADULT; ARTICLE; BONE SCINTISCANNING; CANCER ADJUVANT THERAPY; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; KIDNEY ARTERIOGRAPHY; KIDNEY CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UROGRAPHY;

CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 15044366007     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365590410018701     Document Type: Article

References (19)

1. Peters PC, Brown GL. The role of lymphadenectomy in the management of renal cell carcinoma. Urol Clin North Am 1980;7:705-9.
2. Pizzocaro G, Piva L, Salvioni R. Lymph node dissection in radical nephrectomy for renal cell carcinoma: is it necessary? Eur Urol 1983;9:10-2.
3. Phillips E, Messing EM. Role of lymphadenectomy in the treatment of renal cell carcinoma. Urology 1993;41:9-15.
4. Minervini A, Lilas L, Morelli G, Traversi C, Battaglia S, Cristofani R, et al. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int 2001;88:169-72.
5. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 2003;169:2076-83.
6. Tsukamoto T, Kumamoto Y, Miyao N, Yamazaki K, Takahashi A, Satoh M. Regional lymph node metastasis in renal cell carcinoma: incidence, distribution and its relation to other pathological findings. Eur Urol 1990;18:88-93.
7. Sobin L, Wittekind Ch., editors. TNM classification of malignant tumours, 6th ed. New York: Wiley-Liss; 2002.
8. Blom JH, van Poppel H, Marechal JM, Jacqmin D, Sylvester R, Schroder FH, et al. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group. Eur Urol 1999;36:570-5.
9. Dekernion JB. Lymphadenectomy for renal cell carcinoma. Therapeutic implications. Urol Clin North Am 1980;3:697-703.
10. Hannisdal E, Bostad L, Grottum KA, Langmark F. Erythrocyte sedimentation rate as a prognostic factor in renal cell carcinoma. Eur J Surg Oncol 1989;15:333-6.
11. Ljungberg B, Grankvist K, Rasmuson T. Serum acute phase reactants and prognosis in renal cell carcinoma. Cancer 1995;76:1435-9.
12. Masuda H, Kurita Y, Suzuki A, Kanbayashi T, Suzuki K, Fujita K. Prognostic factors for renal cell carcinoma: a multivariate analysis of 320 cases. Int J Urol 1997;4:247-53.
13. Miyata Y, Koga S, Nishikido M, Noguchi M, Kanda S, Hayashi T, et al. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma. Urology 2001;58:161-4.
14. Onda H, Yasuda M, Serizawa A, Osamura RY, Kawamura N. Clinical outcome in localized renal cell carcinomas related to immunoexpression of proliferating cell nuclear antigen, Ki-67 antigen, and tumor size. Oncol Rep 1999;6;1039-43.
15. Miyake H, Hara S, Arakawa S, Kamidono S, Hara I. Over expression of clusterin is an independent prognostic factor for nonpapillary renal cell carcinoma. J Urol 2002;167:703-6.
16. Ljungberg B, Grankvist K, Rasmuson T. Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma. Eur Urol 1997;33:1794-8.
17. Gelb AB. Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:981-6.
18. Delahunt B, Kittelson JM, McCredie MR, Reeve AE, Stewart JH, Bilous AM. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer 2002;94:658-64.
19. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, et al. TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:992-3.